SARACENI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 853
EU - Europa 378
AS - Asia 133
AF - Africa 33
SA - Sud America 3
OC - Oceania 1
Totale 1.401
Nazione #
US - Stati Uniti d'America 852
IT - Italia 111
SE - Svezia 65
CN - Cina 57
IE - Irlanda 48
UA - Ucraina 47
SG - Singapore 44
DE - Germania 28
MA - Marocco 20
FR - Francia 19
GB - Regno Unito 17
DK - Danimarca 16
TR - Turchia 15
CI - Costa d'Avorio 12
FI - Finlandia 10
BE - Belgio 9
IN - India 9
KR - Corea 7
PL - Polonia 4
BR - Brasile 3
CH - Svizzera 2
AU - Australia 1
CA - Canada 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 1.401
Città #
Chandler 184
Ashburn 64
Des Moines 61
Fairfield 55
Boardman 51
Jacksonville 51
Dublin 48
New York 36
Wilmington 31
Centro 28
Redmond 24
Seattle 24
Lawrence 20
Princeton 20
Woodbridge 18
Cambridge 15
Houston 15
Ann Arbor 13
Turin 13
Abidjan 12
San Mateo 12
San Diego 11
Singapore 11
Washington 10
Brussels 9
Los Angeles 9
Guangzhou 8
Beijing 7
Milan 7
Jesi 5
Civitanova Marche 4
Dallas 4
Leawood 4
Marche 4
Mumbai 4
Palermo 4
Pune 4
Shanghai 4
Wuhan 4
Wuxi 4
Helsinki 3
Rome 3
Vercelli 3
Ancona 2
Cremona 2
Fano 2
Görwihl 2
London 2
Prescot 2
Quanzhou 2
Shenzhen 2
Storo 2
Tianjin 2
Zurich 2
Bologna 1
Casalecchio di Reno 1
Chicago 1
Chiswick 1
Corridonia 1
Edinburgh 1
Falconara Marittima 1
Florence 1
Fuzhou 1
Ganzhou 1
Guarulhos 1
Hangzhou 1
Hengyang 1
Heze 1
Hounslow 1
Jiaxing 1
Jinan 1
Jining 1
Johannesburg 1
Jussari 1
Kagoya 1
Kilburn 1
Lequile 1
Manchester 1
Miami 1
Montesilvano 1
Montreal 1
New Bedfont 1
New Delhi 1
Norwalk 1
Oslo 1
Paris 1
Pescara 1
Philadelphia 1
Porto Recanati 1
Portsmouth 1
Sabará 1
Sant'angelo In Vado 1
Southwark 1
Udine 1
Xi'an 1
Xiangtan 1
Yiwu 1
Totale 986
Nome #
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 106
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 106
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 101
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 93
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 87
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 85
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 80
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 80
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 77
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 76
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 72
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 70
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 67
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 65
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 50
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 46
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 43
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) 38
null 37
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study 35
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 14
Editorial: Reviews in hematologic malignancies 11
null 10
Secondary Acute Myeloid Leukemia: Pathogenesis and Treatment 6
new monoclonal antibodies and tyrosine kinase inhibitors in B-cell acute lymphoblastic leukemia 5
Totale 1.460
Categoria #
all - tutte 8.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 0 0 0 0 12 1 11 2 12 1 5 10
2020/2021214 13 18 22 24 21 4 11 20 20 22 22 17
2021/2022213 7 17 11 9 4 9 25 21 13 17 37 43
2022/2023471 44 55 29 39 39 103 1 24 88 3 35 11
2023/2024223 34 8 15 22 29 68 3 5 0 9 3 27
2024/2025158 65 49 11 16 17 0 0 0 0 0 0 0
Totale 1.460